静脉注射免疫球蛋白市场 - 副产品（IGG、IGA、IGM、IGD、IGE）、应用（低丙种球蛋白血症、CIDP、免疫缺陷疾病、重症肌无力、MMN、ITP）、配销通路（医院、专科）、全球预测，2023 - 2032

在人口老化的推动下，2023 年至 2032 年全球静脉免疫球蛋白市场规模的复合年增长率可能为 7.6%。根据国际货币基金组织的预测，全球预期寿命取得了显着进步，从1913年的仅为34岁上升到2022年的72岁，并且这种上升趋势预计将长期持续。同样，2019年《世界人口展望》修订版的资料显示，到2050年，全球65岁以上人口的比例将从2019年的十一分之一（9%）增至六分之一（16%） 。此外到 2050 年，欧洲和北美将有四分之一的人年龄在 65 岁或以上。

随着年龄的增长，人们的免疫系统可能会减弱，使他们更容易受到各种疾病和病症的影响。 IVIG 是治疗各种自体免疫疾病和免疫缺陷疾病的重要方法。随着全球老年人口的不断增长，对 IVIG 作为治疗选择的需求不断增加，为市场扩张和成长创造了有利的环境。

整个静脉免疫球蛋白市场根据产品、应用、配销通路和地区进行分类。

由于IgE静脉注射免疫球蛋白在治疗严重过敏性疾病和过敏反应中的特殊作用，到2032年，IgE静脉注射免疫球蛋白产业将获得值得注意的估值。随着过敏变得越来越普遍，尤其是在已开发国家，对有效的过敏管理和治疗的需求也越来越大。 IgE 免疫球蛋白为那些经历危及生命的过敏反应的人提供有针对性的缓解，使其成为管理严重过敏和过敏反应的重要组成部分，从而推动了其需求。

重症肌无力领域的静脉注射免疫球蛋白市场份额将在 2023 年至 2032 年期间显着增长，因为由于其免疫调节作用，治疗重症肌无力的 IVIG 的需求量很大。重症肌无力是一种自体免疫神经肌肉疾病，免疫系统会攻击神经肌肉接头，导致肌肉无力。 IVIG 疗法有助于调节免疫反应并缓解症状。随着重症肌无力等自体免疫疾病的盛行率持续上升，对 IVIG 作为治疗选择的需求也增加。

由于多种因素，亚太地区静脉注射免疫球蛋白（IVIG）产业正在不断扩张。医疗基础设施的不断改进、IVIG 疗法意识的提高以及人口老化的不断加剧，导致该地区对免疫球蛋白产品的需求不断增加。此外，该地区自体免疫和免疫缺陷疾病的激增需要 IVIG 治疗。随着医疗保健服务的改善和意识的传播，亚太地区为 IVIG 行业提供了巨大的成长机会。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：静脉免疫球蛋白产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 免疫缺陷疾病的盛行率不断上升
    • 老年人口增加
    • 血浆采集、分离和纯化技术不断进步
    • 增加免疫球蛋白的医疗支出
  • 产业陷阱与挑战
    • IVIG 治疗费用高
    • 潜在的不良反应和过敏反应
    • 血浆捐献者稀缺
• 成长潜力分析
• COVID-19 影响分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：静脉免疫球蛋白市场规模及预测：依产品

• 主要动向：按产品
• 免疫球蛋白G
• 免疫球蛋白A
• 免疫球蛋白M
• 免疫球蛋白D
• 免疫球蛋白E

第 6 章：静脉注射免疫球蛋白市场规模及预测：按应用

• 主要动向：按应用
• 低丙种球蛋白血症
• 慢性发炎性脱髓鞘多发性神经病变（CIDP）
• 免疫缺乏疾病
• 重症肌无力
• 多灶性运动神经病变
• 特发性血小板减少性紫斑症（ITP）
• 发炎性肌肉疾病
• 特异性抗体缺乏
• 格林-巴利综合症
• 其他应用

第 7 章：静脉注射免疫球蛋白市场规模及预测：依配销通路

• 主要动向：按配销通路
• 医院药房
• 专业药房
• 其他分销管道

第 8 章：静脉注射免疫球蛋白市场规模及预测：按地区

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Takeda Pharmaceutical Company Limited.
• Grifols SA
• CSL Behring
• ADMA Biologics
• Octapharma AG
• Baxter International Inc.
• LFB Biotechnologies
• China Biologics Products Inc.
• Kedrion Biopharma
• Intas Pharmaceuticals

Global Intravenous Immunoglobulin Market size could exhibit 7.6% CAGR from 2023 to 2032, driven by the rise in the aging population. According to IMF projections, global life expectancy has shown remarkable progress, rising from just 34 years in 1913 to 72 years in 2022, and this upward trend is expected to persist over the long term. Similarly, data from the 2019 Revision of World Population Prospects reveals that by 2050, the proportion of people aged over 65 in the world will increase to one in six (16%), up from one in eleven (9%) in 2019. Furthermore, by 2050, as many as one in four individuals in Europe and Northern America may be 65 or older.

As people age, their immune systems may weaken, making them more susceptible to various diseases and conditions. IVIG is a crucial treatment for various autoimmune and immunodeficiency disorders. With a growing elderly demographic worldwide, the demand for IVIG as a therapeutic option is increasing, creating a favorable environment for market expansion and growth.

The overall Intravenous Immunoglobulin Market is categorized based on product, application, distribution channel, and region.

IgE Intravenous Immunoglobulin Industry will garner a noteworthy valuation by 2032 due to the specific role of IgE Intravenous Immunoglobulin in treating severe allergic conditions and anaphylactic reactions. As allergies become more prevalent, especially in developed nations, there's a growing need for effective allergy management and treatment. IgE immunoglobulin provides targeted relief for those experiencing life-threatening allergic responses, making it a vital component in managing severe allergies and anaphylaxis, thus driving its demand.

Intravenous immunoglobulin market share from the Myasthenia Gravis segment will grow commendably over 2023-2032 due to the high demand for IVIG in the treatment of Myasthenia Gravis owing to its immunomodulatory effects. Myasthenia Gravis is an autoimmune neuromuscular disorder where the immune system attacks neuromuscular junctions, leading to muscle weakness. IVIG therapy helps to modulate the immune response and alleviate symptoms. As the prevalence of autoimmune diseases like Myasthenia Gravis continues to rise, the demand for IVIG as a treatment option has increased.

Asia Pacific intravenous immunoglobulin (IVIG) industry is expanding due to multiple factors. Increasing healthcare infrastructure, rising awareness of IVIG therapies, and a growing aging population have contributed to the region's increased demand for immunoglobulin products. Moreover, a surge in autoimmune and immunodeficiency disorders in the region necessitates IVIG treatment. As healthcare access improves and awareness spreads, the Asia Pacific region offers significant growth opportunities for the IVIG industry.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Intravenous immunoglobulin industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product trends
  • 2.1.4 Application trends
  • 2.1.5 Distribution channel trends

Chapter 3 Intravenous Immunoglobulin Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of immunodeficiency disorders
    • 3.2.1.2 Increasing geriatric population
    • 3.2.1.3 Growing advances in plasma collection, fractionation, and purification technologies
    • 3.2.1.4 Increasing healthcare expenditure for immunoglobulins
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of IVIG therapy
    • 3.2.2.2 Potential adverse effects and allergic reactions
    • 3.2.2.3 Scarcity of plasma donors
• 3.3 Growth potential analysis
  • 3.3.1 By product
  • 3.3.2 By application
  • 3.3.3 By distribution channel
• 3.4 COVID- 19 impact analysis
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategy dashboard, 2022

Chapter 5 Intravenous Immunoglobulin Market Size and Forecast, By Product (USD Million)

• 5.1 Key trends, by product
• 5.2 IgG
• 5.3 IgA
• 5.4 IgM
• 5.5 IgD
• 5.6 IgE

Chapter 6 Intravenous Immunoglobulin Market Size and Forecast, By Application (USD Million)

• 6.1 Key trends, by application
• 6.2 Hypogammaglobulinemia
• 6.3 Chronic Inflammatory demyelinating polyneuropathy (CIDP)
• 6.4 Immunodeficiency diseases
• 6.5 Myasthenia gravis
• 6.6 Multifocal motor neuropathy
• 6.7 Idiopathic thrombocytopenic purpura (ITP)
• 6.8 Inflammatory myopathies
• 6.9 Specific antibody deficiency
• 6.10 Guillain-Barre syndrome
• 6.11 Other applications

Chapter 7 Intravenous Immunoglobulin Market Size and Forecast, By Distribution Channel (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Hospital pharmacy
• 7.3 Specialty pharmacy
• 7.4 Other distribution channels

Chapter 8 Intravenous Immunoglobulin Market Size and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Takeda Pharmaceutical Company Limited.
• 9.2 Grifols SA
• 9.3 CSL Behring
• 9.4 ADMA Biologics
• 9.5 Octapharma AG
• 9.6 Baxter International Inc.
• 9.7 LFB Biotechnologies
• 9.8 China Biologics Products Inc.
• 9.9 Kedrion Biopharma
• 9.10 Intas Pharmaceuticals

Data Tables

• TABLE 1. Product mapping
• TABLE 2. Market revenue, by product (2022)
• TABLE 3. Market revenue, by application (2022)
• TABLE 4. Market share, by distribution channel (2022)
• TABLE 5. Market share, by region (2022)
• TABLE 6. Global intravenous immunoglobulin market size, 2018-2022, (USD Million)
• TABLE 7. Global intravenous immunoglobulin market size, 2023-2032, (USD Million)
• TABLE 8. Global intravenous immunoglobulin market size, by region, 2018-2022 (USD Million)
• TABLE 9. Global intravenous immunoglobulin market size, by region, 2023-2032 (USD Million)
• TABLE 10. Global intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 11. Global intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 12. Global intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 13. Global intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 14. Global intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 15. Global intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 16. Industry impact forces
• TABLE 17. IgG market size, 2018-2022 (USD Million)
• TABLE 18. IgG market size, 2023-2032 (USD Million)
• TABLE 19. IgA market size, 2018-2022 (USD Million)
• TABLE 20. IgA market size, 2023-2032 (USD Million)
• TABLE 21. IgM market size, 2018-2022 (USD Million)
• TABLE 22. IgM market size, 2023-2032 (USD Million)
• TABLE 23. IgD market size, 2018-2022 (USD Million)
• TABLE 24. IgD market size, 2023-2032 (USD Million)
• TABLE 25. IgE market size, 2018-2022 (USD Million)
• TABLE 26. IgE market size, 2023-2032 (USD Million)
• TABLE 27. Hypogammaglobulinemia market size, 2018-2022 (USD Million)
• TABLE 28. Hypogammaglobulinemia market size, 2023-2032 (USD Million)
• TABLE 29. Chronic Inflammatory demyelinating polyneuropathy (CIDP) market size, 2018-2022 (USD Million)
• TABLE 30. Chronic Inflammatory demyelinating polyneuropathy (CIDP) market size, 2023-2032 (USD Million)
• TABLE 31. Immunodeficiency diseases market size, 2018-2022 (USD Million)
• TABLE 32. Immunodeficiency diseases market size, 2023-2032 (USD Million)
• TABLE 33. Myasthenia gravis market size, 2018-2022 (USD Million)
• TABLE 34. Myasthenia gravis market size, 2023-2032 (USD Million)
• TABLE 35. Multifocal motor neuropathy market size, 2018-2022 (USD Million)
• TABLE 36. Multifocal motor neuropathy market size, 2023-2032 (USD Million)
• TABLE 37. Idiopathic thrombocytopenic purpura (ITP) market size, 2018-2022 (USD Million)
• TABLE 38. Idiopathic thrombocytopenic purpura (ITP) market size, 2023-2032 (USD Million)
• TABLE 39. Inflammatory myopathies market size, 2018-2022 (USD Million)
• TABLE 40. Inflammatory myopathies market size, 2023-2032 (USD Million)
• TABLE 41. Specific antibody deficiency market size, 2018-2022 (USD Million)
• TABLE 42. Specific antibody deficiency market size, 2023-2032 (USD Million)
• TABLE 43. Guillain-Barre syndrome market size, 2018-2022 (USD Million)
• TABLE 44. Guillain-Barre syndrome market size, 2023-2032 (USD Million)
• TABLE 45. Other applications market size, 2018-2022 (USD Million)
• TABLE 46. Other applications market size, 2023-2032 (USD Million)
• TABLE 47. Hospital pharmacy market size, 2018-2022 (USD Million)
• TABLE 48. Hospital pharmacy market size, 2023-2032 (USD Million)
• TABLE 49. Specialty pharmacy market size, 2018-2022 (USD Million)
• TABLE 50. Specialty pharmacy market size, 2023-2032 (USD Million)
• TABLE 51. Other distribution channels market size, 2018-2022 (USD Million)
• TABLE 52. Other distribution channels market size, 2023-2032 (USD Million)
• TABLE 53. North America intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 54. North America intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 55. North America intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 56. North America intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 57. North America intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 58. North America intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 59. North America intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 60. North America intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 61. U.S. intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 62. U.S. intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 63. U.S. intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 64. U.S. intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 65. U.S. intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 66. U.S. intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 67. Canada intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 68. Canada intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 69. Canada intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 70. Canada intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 71. Canada intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 72. Canada intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 73. Europe intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 74. Europe intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 75. Europe intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 76. Europe intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 77. Europe intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 78. Europe intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 79. Europe intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 80. Europe intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 81. Germany intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 82. Germany intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 83. Germany intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 84. Germany intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 85. Germany intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 86. Germany intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 87. UK intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 88. UK intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 89. UK intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 90. UK intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 91. UK intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 92. UK intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 93. France intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 94. France intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 95. France intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 96. France intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 97. France intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 98. France intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 99. Italy intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 100. Italy intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 101. Italy intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 102. Italy intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 103. Italy intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 104. Italy intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 105. Spain intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 106. Spain intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 107. Spain intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 108. Spain intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 109. Spain intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 110. Spain intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 111. Rest of Europe intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 112. Rest of Europe intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 113. Rest of Europe intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 114. Rest of Europe intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 115. Rest of Europe intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 116. Rest of Europe intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 117. Asia Pacific intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 118. Asia Pacific intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 119. Asia Pacific intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 120. Asia Pacific intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 121. Asia Pacific intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 122. Asia Pacific intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 123. Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 124. Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 125. Japan intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 126. Japan intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 127. Japan intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 128. Japan intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 129. Japan intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 130. Japan intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 131. China intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 132. China intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 133. China intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 134. China intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 135. China intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 136. China intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 137. India intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 138. India intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 139. India intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 140. India intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 141. India intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 142. India intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 143. Australia intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 144. Australia intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 145. Australia intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 146. Australia intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 147. Australia intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 148. Australia intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 149. South Korea intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 150. South Korea intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 151. South Korea intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 152. South Korea intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 153. South Korea intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 154. South Korea intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 155. Rest of Asia Pacific intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 156. Rest of Asia Pacific intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 157. Rest of Asia Pacific intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 158. Rest of Asia Pacific intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 159. Rest of Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 160. Rest of Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 161. Latin America intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 162. Latin America intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 163. Latin America intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 164. Latin America intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 165. Latin America intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 166. Latin America intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 167. Latin America intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 168. Latin America intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 169. Brazil intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 170. Brazil intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 171. Brazil intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 172. Brazil intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 173. Brazil intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 174. Brazil intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 175. Mexico intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 176. Mexico intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 177. Mexico intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 178. Mexico intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 179. Mexico intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 180. Mexico intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 181. Rest of Latin America intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 182. Rest of Latin America intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 183. Rest of Latin America intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 184. Rest of Latin America intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 185. Rest of Latin America intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 186. Rest of Latin America intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 187. Middle East & Africa intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 188. Middle East & Africa intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 189. Middle East & Africa intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 190. Middle East & Africa intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 191. Middle East & Africa intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 192. Middle East & Africa intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 193. Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 194. Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 195. South Africa intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 196. South Africa intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 197. South Africa intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 198. South Africa intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 199. South Africa intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 200. South Africa intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 201. Saudi Arabia intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 202. Saudi Arabia intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 203. Saudi Arabia intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 204. Saudi Arabia intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 205. Saudi Arabia intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 206. Saudi Arabia intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 207. Rest of Middle East & Africa intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 208. Rest of Middle East & Africa intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 209. Rest of Middle East & Africa intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 210. Rest of Middle East & Africa intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 211. Rest of Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 212. Rest of Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

• FIG. 1 Industry segmentation
• FIG. 2 Top-down approach
• FIG. 3 Market estimation and forecast
• FIG. 4 Market forecasting methodology
• FIG. 5 Breakdown of primary participants
• FIG. 6 Intravenous immunoglobulin industry, 360 degree synopsis, 2018 - 2032
• FIG. 7 Industry landscape, 2018-2032 (USD Million)
• FIG. 8 Growth potential analysis, by product
• FIG. 9 Growth potential analysis, by application
• FIG. 10 Growth potential analysis, by distribution channel
• FIG. 11 Porter's analysis
• FIG. 12 PESTEL analysis
• FIG. 13 Company matrix analysis, 2022
• FIG. 14 Strategy dashboard, 2022